Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
555.00    -14.00 (-2.46%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.46b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

2 Mar 2016 11:37

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the ‘Company’) was informed yesterday that 3,119 ordinary shares of 25 pence each in the capital of the Company (‘Shares’) were allotted on 1 March 2016 under the Tate & Lyle 2001 Sharesave Scheme to Rob Luijten, a Person Discharging Managerial Responsibilities. The option price was 488.00 pence per Share and the transaction took place in London. Mr Luijten has retained all the shares allotted to him.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

2 March 2016

View source version on businesswire.com: http://www.businesswire.com/news/home/20160302005676/en/

Copyright Business Wire 2016

Date   Source Headline
18th Jun 20269:21 amRNSForm 8.5 (EPT/RI) Amend - Tate & Lyle PLC
18th Jun 20269:07 amRNSForm 8.5 (EPT/RI)
18th Jun 20269:05 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
18th Jun 20269:05 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
17th Jun 20263:23 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
17th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 20263:14 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
17th Jun 20263:11 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
17th Jun 20263:10 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
17th Jun 20263:00 pmRNSForm 8.5 (EPT/RI)-Amend-Tate & Lyle PLC
17th Jun 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 20262:59 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 20262:23 pmRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
17th Jun 20262:22 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 20262:22 pmRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
17th Jun 20261:47 pmRNSForm 8.3 TATE & LYLE PLC
17th Jun 202612:22 pmRNSForm 8.3 - Tate & Lyle Plc
17th Jun 202612:04 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 202612:00 pmRNSForm 8.3 - Tate & Lyle plc
17th Jun 202611:51 amRNSForm 8.5 Tate & Lyle Plc
17th Jun 202611:39 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
17th Jun 202611:24 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
17th Jun 202611:20 amRNS20260616_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
17th Jun 202611:18 amRNS20260616_TATE & LYLE_8.5 EPT RI_UK_MLI
17th Jun 202611:13 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
17th Jun 202611:08 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
17th Jun 202611:05 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
17th Jun 202610:27 amRNSForm 8.3 Tate & Lyle Plc
17th Jun 202610:19 amRNSForm 8.3 - Tate & Lyle plc
17th Jun 20268:57 amRNSForm 8.5 (EPT/RI)
16th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
16th Jun 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
16th Jun 20262:46 pmRNSForm 8.3 Tate & Lyle Plc
16th Jun 20262:06 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
16th Jun 20261:55 pmRNSForm 8.3 TATE & LYLE PLC
16th Jun 202612:04 pmRNSForm 8.3 Tate & Lyle plc
16th Jun 202611:42 amRNSForm 8.3 - Tate & Lyle plc
16th Jun 202611:35 amRNSForm 8.5 Tate & Lyle Plc
16th Jun 202611:31 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
16th Jun 202611:26 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
16th Jun 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
16th Jun 202611:13 amRNSForm 8.3 - Tate & Lyle plc
16th Jun 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
16th Jun 202611:07 amRNS20260615_TATE & LYLE_8.5 EPT RI_UK_MLI
16th Jun 202610:03 amRNSForm 8.3 Tate & Lyle Plc
16th Jun 202610:03 amRNSForm 8.3 Tate & Lyle Plc
16th Jun 20269:09 amRNSForm 8.5 (EPT/RI)
16th Jun 20267:00 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
15th Jun 20263:21 pmRNSForm 8.3 Tate & Lyle Plc
15th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.